Table 1.
ID | Gender | Age | Treatment Group | WHO PS | Trial Arm | Carer interview | Gender |
---|---|---|---|---|---|---|---|
216 | Female | 61 | Post‐curative intent treatment | 2 | Control | No | |
217 | Male | 63 | Post‐curative intent treatment | 1 | Intervention | Yes | Female |
303 | Female | 65 | Post‐curative intent treatment | 2 | Intervention | Yes | Male |
312 | Female | 70 | Palliative cancer therapy follow‐up | 1 | Control | No | |
315 | Female | 64 | Palliative cancer therapy follow‐up | 1 | Intervention | No | |
317 | Male | 78 | Post‐curative intent treatment | 1 | Intervention | No | |
318 | Female | 63 | Palliative cancer therapy follow‐up | 2 | Control | No | |
408 | Male | 64 | Post‐curative intent treatment | 0 | Control | Yes | Female |
409 | Female | 63 | Palliative cancer therapy follow‐up | 1 | Intervention | No | |
505 | Male | 77 | Palliative cancer therapy follow‐up | 1 | Control | No | |
604 | Male | 78 | Post‐curative intent treatment | 2 | Control | No |
WHO PS, WHO Performance Status: 0 = fully active; can't carry out heavy physical work; 2 = up and about more than half the day; 3 = in bed or a chair for more than half the day; 4 = in bed or a chair all the time and need complete care (Trial inclusion criteria WHO PS 0–2).